Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Marcos Iglesias-Campos"'
Autor:
Gonzalo Lendinez-Sanchez, Tamara Diaz-Redondo, Marcos Iglesias-Campos, Lucía Garrido-Almazán, Emilio Alba-Conejo, Antonio Rueda-Dominguez, Alfonso Sanchez-Muñoz
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionThe incidence of brain metastases in ovarian cancer is quite rare, being approximately 1%–2%. According to retrospective studies, patients with BRCA 1/2 mutations present a higher risk. The trimodal approach based on surgery, radiothera
Externí odkaz:
https://doaj.org/article/eb53345f21fd4a00a66d787da3ea0e13
Autor:
Adrian Escriche-Escuder, Manuel Trinidad-Fernández, Bella Pajares, Marcos Iglesias-Campos, Emilio Alba, José Manuel García-Almeida, Cristina Roldán-Jiménez, Antonio I. Cuesta-Vargas
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Ultrasound imaging texture analyses may provide information on tissue homogeneity changes in metastatic breast cancer (MBC) through second-order analyzes based on the gray-level co-occurrence matrix. This study aimed to analyze the responsiv
Externí odkaz:
https://doaj.org/article/bc634c3f4c8d40719307d9ed3188229e
Autor:
Adrian Escriche-Escuder, Manuel Trinidad-Fernández, Bella Pajares, Marcos Iglesias-Campos, Emilio Alba, Antonio I. Cuesta-Vargas, Cristina Roldán-Jiménez
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Changes in body composition and muscle dysfunction are common in metastatic breast cancer (MBC). Ultrasound imaging (US) offers reliable information about muscle and fat tissue architecture (thickness) and quality (echo-intensity). This stud
Externí odkaz:
https://doaj.org/article/f712c4c916254502b38875915f1cefa2
Forearm Muscle Activity During the Handgrip Test in Breast Cancer Survivors: A Cross-Sectional Study
Autor:
Iván José Fuentes-Abolafio, Cristina Roldán-Jiménez, Marcos Iglesias Campos, Bella I Pajares-Hachero, Emilio Alba-Conejo, Antonio Cuesta-Vargas
Publikováno v:
Clinical Breast Cancer. 23:e175-e181
Autor:
David Pérez‐Cruzado, Cristina Roldan‐Jimenez, Marcos Iglesias‐Campos, Bella Pajares, Emilio Alba, Antonio Cuesta‐Vargas
Publikováno v:
Pain practice : the official journal of World Institute of PainREFERENCES. 22(8)
Pain catastrophizing scale (PCS) is the most used scale to measure pain catastrophizing. In breast cancer survivors (BCS), pain catastrophizing is related to upper-limbs dysfunction and disability. This study aimed to assess the internal consistency,
Autor:
Manuel Trinidad-Fernández, Daniel Gutiérrez-Sánchez, Bella Pajares, Marcos Iglesias Campos, Emilio Alba, Antonio Cuesta-Vargas, Nuria Ribelles, Cristina Roldán-Jiménez
Publikováno v:
Pain Practice. 21:740-746
Introduction One of the most widely used instruments to identify symptoms that may be related to central sensitization is the Central Sensitization Inventory (CSI). Although this instrument has been translated and validated in Spanish patients with c
Autor:
Antonio Cuesta-Vargas, Jena Buchan, Emilio Alba, Marcos Iglesias Campos, Cristina Roldán-Jiménez, Bella Pajares
To develop a physical function test based on lie-to-sit transition and to study its feasibility in patients suffering from metastatic breast cancer (MBC). This cross-sectional study recruited 90 women diagnosed with MBC. Patients were asked to transf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4019697c8b637d83fa3c30ea06368f1e
Autor:
Alfonso Yubero-Esteban, Piedad Reche-Molina, Carmen Salvador Coloma, Purificación Estévez-García, Luis Manso, Marcos Iglesias Campos, Arantzazu Barquin, Raul Marquez, Ana Santaballa, Julia Calzas, Ana Herrero, Victoria Casado, Julia Madani, Maria Merino, Gloria Marquina, Jesus Alarcon Company, Lydia Gaba, Jose Fuentes Pradera, Antonio Gonzalez Martin, Maria Luisa Sanchez Lorenzo
Publikováno v:
Journal of Clinical Oncology. 40:e17598-e17598
e17598 Background: Rucaparib is a PARP inhibitor (PARPi) approved as maintenance therapy for platinum (Pt)-sensitive recurrent high-grade ovarian cancer (HGOC), and as treatment for BRCA-mutant HGOC patients. To date, there is little evidence about t
Autor:
Alfonso Yubero-Esteban, Arantzazu Barquin, Lydia Gaba, Marcos Iglesias Campos, Piedad Reche-Molina, Carmen Salvador Coloma, Jesus Alarcon Company, Luis Manso, Raul Marquez, Jose Fuentes Pradera, Julia Madani, Manuel Constenla Figueiras, Maria Gutierrez-Toribio, Purificación Estévez-García, Ana Santaballa, Maria Luisa Sanchez Lorenzo, Julia Calzas, Ana Herrero, Alvaro Taus, Antonio Gonzalez Martin
Publikováno v:
Journal of Clinical Oncology. 40:e17562-e17562
e17562 Background: Rucaparib is a PARP inhibitor approved for the treatment of high-grade ovarian cancer (HGOC). Clinical trials have demonstrated its benefit both as maintenance therapy (MTN) for platinum (Pt)-sensitive recurrent HGOC, and as treatm
Autor:
Bella Pajares, Marcos Iglesias-Campos, Cristina Roldán-Jiménez, Adrian Escriche-Escuder, Antonio Cuesta-Vargas, Manuel Trinidad-Fernández, Emilio Alba
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Changes in body composition and muscle dysfunction are common in metastatic breast cancer (MBC). Ultrasound imaging (US) offers reliable information about muscle and fat tissue architecture (thickness) and quality (echo-intensity). This study aimed t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e314964aa29bd73ebfaeec224300c3c9
https://hdl.handle.net/10668/17625
https://hdl.handle.net/10668/17625